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DrChristos Liapis (Athens, Greece). Excellent paper. I have one
question and one comment. Did you analyze separately patients with
typeA and typeBdiabetes? Andmy comment is that only 35%of your
patients in both groups were on statins, yet, the main statisticalDrEnrico Cieri.We did not analyze specifically type A and type
diabetes, but our aged population was mainly affected by type B
iabetes independently of their current use of insulin or oral hypogly-
emic agents. But I am sorry. I have no data about type A and type B
iabetes. And for sure, statins is a very protective factor for both the
rocedures (endarterectomy and stenting). I agree absolutely with you.
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Volume 55, Number 1 Parlani et al 89Dr John Ricotta (Washington, DC). Do you have data on
hemoglobin A1C levels in the two patient groups that might give
us an idea of whether they were comparable at the time of surgery?
Do you have any data on that?
DrCieri.No, I am sorry, because the study was a retrospective
analysis of a prospective database and we did not record this data.
DrRicotta.Do you think that the fact that there seemed to be
a greater burden of atherosclerosis in the endarterectomy patients,
for example, they had more peripheral vascular disease and more
tortuous arch anatomy, do you think that might influence your
results in any way?
Dr Cieri. I really think that diabetes is in itself a marker of a
poor systemic condition, and several studies are analyzing the
effect of diabetes or its medications (eg, insulin) on the inflamma-
tory process of atherosclerosis. So, I think that the surgical stress in
carotid endarterectomy might be a key point in diabetic patients’
risk and this, more than arch or vessel anatomy, might have
influenced our results.
e
aDr Jean-Baptiste Ricco (Poitiers, France). Did you do any
ropensity analysis between carotid stenting vs carotid endarterec-
omy to make sure that the observed effect is not due to differences
n participants in the two groups rather than or in addition to the
ntervention?
Dr Cieri. No, we did not perform propensity analysis. Really,
he aim of our study was not to compare carotid endarterectomy
ith carotid stenting, but to see whether diabetes could affect in
arotid revascularization, whichever the technique used. So we did
ot perform a propensity adjustment of patients for carotid endar-
erectomy vs carotid stenting.
Dr Robert Zwolak (Lebanon, NH). Did you have equal
ercentages of symptomatic and asymptomatic patients in the
ndarterectomy and carotid stenting groups?
Dr Cieri. Yes. No statistical difference was found in distribu-
ion of symptomatic and asymptomatic patients between carotid
ndarterectomy and carotid stenting group or between diabetic
nd nondiabetic patients.
